Depression and Associated Factors in Patients with Implantable Cardioverter-Defibrillators

Maryam Moshkani Farahani1, Mehrdad Taghipour2, Mohsen Motalebi2

  • 1Atherosclerosis Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Insights

Depression is common in patients with implantable cardioverter-defibrillators (ICDs). Factors like ICD shocks, male sex, hospital admissions, smoking cessation, dyslipidemia, and family history of depression are linked to higher depression scores.

Area of Science:

  • Cardiology
  • Psychiatry
  • Medical Psychology

Background:

  • Psychological distress, particularly depression, is a significant concern for individuals with implantable cardioverter-defibrillators (ICDs).
  • These psychological issues can negatively impact the quality of life for patients managing cardiac conditions with ICDs.

Purpose of the Study:

  • To determine the prevalence of depression among adult patients who have received an ICD.
  • To investigate the relationship between depression and various associated factors in this patient population.

Main Methods:

  • A cross-sectional study was conducted with 115 adult patients implanted with an ICD in Tehran, Iran.
  • Data were collected using questionnaires assessing demographic characteristics and depression levels via the Beck Depression Inventory.

Main Results:

  • Multivariate analysis identified several independent predictors of depression scores in ICD patients.
  • Significant associations were found with frequency and presence of ICD shocks, male sex, increased hospital admissions, smoking cessation, dyslipidemia, and a family history of depression.

Conclusions:

  • The study highlights that a range of predictable and preventable factors contribute to poor psychosocial outcomes in patients with ICDs.
  • Interventions targeting these identified risk factors may improve mental health and quality of life for individuals with ICDs.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
677
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
477
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
796
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
722